These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10084289)

  • 1. Beneficial effects of iron therapy in renal failure patients on hemodialysis.
    Fishbane S; Mittal SK; Maesaka JK
    Kidney Int Suppl; 1999 Mar; 69():S67-70. PubMed ID: 10084289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Iron replacement in hemodialysis patients with a normal serum ferritin level].
    Riedel MK; Morgenstern T
    Dtsch Med Wochenschr; 2004 Sep; 129(36):1849-53. PubMed ID: 15368155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance therapy with intravenous iron in hemodialysis patients receiving erythropoietin.
    Kotaki M; Uday K; Henriquez M; Blum S; Dave M
    Clin Nephrol; 1997 Jul; 48(1):63-4. PubMed ID: 9247787
    [No Abstract]   [Full Text] [Related]  

  • 4. Iron status and iron supplementation in peritoneal dialysis patients.
    Vychytil A; Haag-Weber M
    Kidney Int Suppl; 1999 Mar; 69():S71-8. PubMed ID: 10084290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.
    Drüeke TB; Bárány P; Cazzola M; Eschbach JW; Grützmacher P; Kaltwasser JP; Macdougall IC; Pippard MJ; Shaldon S; van Wyck D
    Clin Nephrol; 1997 Jul; 48(1):1-8. PubMed ID: 9247771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for iron supplementation: oral versus intravenous.
    Macdougall IC
    Kidney Int Suppl; 1999 Mar; 69():S61-6. PubMed ID: 10084288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitating iron balance in hemodialysis patients.
    Eschbach JW; Cook JD
    Trans Am Soc Artif Intern Organs; 1977; 23():54-8. PubMed ID: 910378
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation and treatment of iron deficiency in patients with kidney disease.
    Bickford AK
    Nutr Clin Care; 2002; 5(5):225-30. PubMed ID: 12455224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical practice guidelines for maintaining adequate iron status with intravenous iron dextran in hemodialysis patients.
    Peacock E; Lindenfeld SM
    ANNA J; 1999 Jun; 26(3):337-43. PubMed ID: 10633605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment with low doses of intravenous iron does not modify hemoglobin nor the erythropoietin dosage].
    Fernández-Gallego J; Martín MA; Alonso A; Toledo R
    Nefrologia; 2006; 26(1):143-4. PubMed ID: 16649439
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical practice guidelines for assessment and management of iron deficiency.
    Madore F; White CT; Foley RN; Barrett BJ; Moist LM; Klarenbach SW; Culleton BF; Tonelli M; Manns BJ;
    Kidney Int Suppl; 2008 Aug; (110):S7-S11. PubMed ID: 18668119
    [No Abstract]   [Full Text] [Related]  

  • 12. Maintaining higher TSATs and other iron indices is beneficial in management of anemic hemodialysis patients.
    Besarab A; Dalton CL
    Nephrol Nurs J; 2001 Aug; 28(4):429-34. PubMed ID: 12143465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resolving the paradigm crisis in intravenous iron and erythropoietin management.
    Besarab A
    Kidney Int Suppl; 2006 May; (101):S13-8. PubMed ID: 16830701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of subcutaneous low-dose erythropoietin in patients with chronic renal failure despite functional iron deficiency.
    Bedani PL; Cecchetti E; Gilli P
    Nephron; 1995; 71(4):459-60. PubMed ID: 8587628
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral use of iron with vitamin C in hemodialyzed patients.
    Mydlík M; Derzsiová K; Boldizsár J; Hríbiková M; Petrovicová J
    J Ren Nutr; 2003 Jan; 13(1):47-51. PubMed ID: 12563623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with zinc protoporphyrin as a marker of endogenous iron availability in chronic haemodialysis patients.
    Baldus M; Salopek S; Möller M; Schliesser J; Klooker P; Reddig J; Gansert U; Brass H
    Nephrol Dial Transplant; 1996 Mar; 11(3):486-91. PubMed ID: 8710158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of iron metabolism on the efficacy of r-HuEPO (recombinant human erythropoietin) treatment of anemia in children on hemodialysis].
    Pela I; Lavoratti GC; Materassi M; Burgio G; Bartolozzi G
    Pediatr Med Chir; 1991; 13(5):475-7. PubMed ID: 1788107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenging the boundaries of anemia management: a balanced approach to i.v. iron and EPO therapy.
    Coyne D
    Kidney Int Suppl; 2006 May; (101):S1-3. PubMed ID: 16830698
    [No Abstract]   [Full Text] [Related]  

  • 19. Content of reticulocyte hemoglobin is a reliable tool for determining iron deficiency in dialysis patients.
    Tsuchiya K; Okano H; Teramura M; Iwamoto Y; Yamashita N; Suda A; Shimada K; Nihei H; Ando M
    Clin Nephrol; 2003 Feb; 59(2):115-23. PubMed ID: 12608554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron management in end-stage renal disease.
    Fishbane S; Maesaka JK
    Am J Kidney Dis; 1997 Mar; 29(3):319-33. PubMed ID: 9041207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.